These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24239386)
1. Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma. Kennedy C; Bull K; Chevignard M; Culliford D; Dörr HG; Doz F; Kortmann RD; Lannering B; Massimino M; Navajas Gutiérrez A; Rutkowski S; Spoudeas HA; Calaminus G; Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):292-300. PubMed ID: 24239386 [TBL] [Abstract][Full Text] [Related]
2. Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy. Câmara-Costa H; Resch A; Kieffer V; Lalande C; Poggi G; Kennedy C; Bull K; Calaminus G; Grill J; Doz F; Rutkowski S; Massimino M; Kortmann RD; Lannering B; Dellatolas G; Chevignard M; Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):978-985. PubMed ID: 26194675 [TBL] [Abstract][Full Text] [Related]
9. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. Evans AE; Jenkin RD; Sposto R; Ortega JA; Wilson CB; Wara W; Ertel IJ; Kramer S; Chang CH; Leikin SL J Neurosurg; 1990 Apr; 72(4):572-82. PubMed ID: 2319316 [TBL] [Abstract][Full Text] [Related]
10. Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy. Gupta T; Jalali R; Goswami S; Nair V; Moiyadi A; Epari S; Sarin R Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1534-40. PubMed ID: 22342098 [TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. Gajjar A; Mulhern RK; Heideman RL; Sanford RA; Douglass EC; Kovnar EH; Langston JA; Jenkins JJ; Kun LE J Clin Oncol; 1994 Jun; 12(6):1212-6. PubMed ID: 8201384 [TBL] [Abstract][Full Text] [Related]
12. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma. Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589 [TBL] [Abstract][Full Text] [Related]
13. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Padovani L; Sunyach MP; Perol D; Mercier C; Alapetite C; Haie-Meder C; Hoffstetter S; Muracciole X; Kerr C; Wagner JP; Lagrange JL; Maire JP; Cowen D; Frappaz D; Carrie C Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):433-40. PubMed ID: 17498567 [TBL] [Abstract][Full Text] [Related]
14. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma. Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547 [TBL] [Abstract][Full Text] [Related]
15. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups. Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ; Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563 [TBL] [Abstract][Full Text] [Related]
16. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538 [TBL] [Abstract][Full Text] [Related]
17. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826 [TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Huang E; Teh BS; Strother DR; Davis QG; Chiu JK; Lu HH; Carpenter LS; Mai WY; Chintagumpala MM; South M; Grant WH; Butler EB; Woo SY Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):599-605. PubMed ID: 11849779 [TBL] [Abstract][Full Text] [Related]
19. Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91. von Bueren AO; von Hoff K; Benesch M; Rutkowski S Klin Padiatr; 2009; 221(6):396-7. PubMed ID: 19890797 [No Abstract] [Full Text] [Related]
20. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma. Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]